PLASMA FIBRINOGEN LEVEL INDEPENDENTLY PREDICTS THE PROGNOSIS OF PATIENTS WITH NON-METASTATIC RENAL CELL CARCINOMA

被引：0
|
作者：
Obata, Jun
Tanaka, Nobuyuki
Mizuno, Ryuichi
Morita, Shinya
Shinoda, Kazunobu
Kosaka, Takeo
Shinojima, Toshiaki
Kikuchi, Eiji
Asanuma, Hiroshi
Miyajima, Akira
Oya, Mototsugu
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP35-20
引用
收藏
页码：E427 / E427
页数：1
相关论文
共 50 条
  • [21] Adjuvant activated T-cell (ATC) therapy for patients with non-metastatic or resected metastatic renal cell carcinoma
    Treisman, J. S.
    Morris, R.
    Garlie, N.
    Lefever, A.
    Hanson, J. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [22] A preoperative clinical prognostic model for non-metastatic renal cell carcinoma
    Cindolo, L
    de la Taille, A
    Messina, G
    Romis, L
    Abbou, CC
    Altieri, V
    Rodriguez, A
    Patard, JJ
    BJU INTERNATIONAL, 2003, 92 (09) : 901 - 905
  • [23] Plasma fibrinogen as prognostic predictor in patients with metastatic renal cell carcinoma receiving target therapy
    Wang, Lihe
    Cai, Wen
    Kong, Wen
    Zhang, Jin
    Chen, Yonghui
    Huang, Jiwei
    Huang, Yiran
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (06) : 1384 - 1392
  • [24] High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma
    Xu, Zhiying
    Liu, Yidong
    Yang, Yuanfeng
    Wang, Jieti
    Zhang, Guodong
    Liu, Zheng
    Fu, Hangcheng
    Wang, Zewei
    Liu, Haiou
    Xu, Jiejie
    ONCOTARGET, 2017, 8 (05) : 7548 - 7558
  • [25] Prognostic impact of peripheral blood counts in patients with non-metastatic clear cell renal cell carcinoma
    Hammond, William Adam
    Lewis, Daniel
    Hassan, Lauren
    Serie, Daniel
    Thai Huu Ho
    Eckel-Passow, Jeanette
    Leibovich, Bradley C.
    Thompson, Robert Houston
    Cheville, John C.
    Parker, Alexander S.
    Joseph, Richard Wayne
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] Outcome of sentinel lymph node biopsy in patients with clinically non-metastatic renal cell carcinoma
    Kuusk, Teele
    De Bruijn, Roderick
    Brouwer, Oscar R.
    De Jong, Jeroen
    Donswijk, Maarten
    Hendricksen, Kees
    Horenblas, Simon
    Jozwiak, Katarzyna
    Prevoo, Warner
    Olmos, Renato A. Valdes
    Van Der Poel, Henk G.
    Van Rhijn, Bas W. G.
    Wit, Esther M.
    Bex, Axel
    SCANDINAVIAN JOURNAL OF UROLOGY, 2018, 52 (5-6) : 411 - 418
  • [27] Predictors of postoperative recurrence in patients with non-metastatic pT3a renal cell carcinoma
    Ohsugi, Haruyuki
    Ohe, Chisato
    Yoshida, Takashi
    Ikeda, Junichi
    Sugi, Motohiko
    Kinoshita, Hidefumi
    Matsuda, Tadashi
    INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (10) : 1060 - 1066
  • [28] IMPACT OF NECROTIC AND SARCOMATOID COMPONENTS ON ONCOLOGICAL OUTCOMES IN PATIENTS WITH NON-METASTATIC RENAL CELL CARCINOMA
    Yoo, Sangjun
    Ryu, Jeman
    Chae, Han-Kyu
    Han, Jae Hyeon
    Choi, Se Young
    You, Dalsan
    Jeong, In Gab
    Song, Cheryn
    Hong, Bumsik
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    JOURNAL OF UROLOGY, 2017, 197 (04): : E730 - E730
  • [29] A COMPARISON OF OPEN RADICAL NEPHRECTOMY COMPLICATION RATES IN PATIENTS TREATED WITH NEOADJUVANT SUNITINIB FOR METASTATIC RENAL CELL CARCINOMA VERSUS NON-METASTATIC RENAL CELL CARCINOMA
    Hussain, M.
    Nair, R.
    Bycroft, J.
    Green, J. S. A.
    Powles, T.
    Peters, J. L.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 103 - 103
  • [30] Editorial Comment to p21-activated kinase 1 predicts recurrence and survival in patients with non-metastatic clear cell renal cell carcinoma
    Yuasa, Takeshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (05) : 453 - 454
12345